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ABSTRACT
A 43-year-old man presented with persistent wrist
pain and loss of range of motion after nonoperative
therapy. Magnetic resonance imaging showed features
consistent with pigmented villonodular synovitis (PVNS)
of the scaphotrapeziotrapezoidal joint. He underwent
arthroscopic excision and synovectomy. At 2 years
postoperatively, he had no symptomatic recurrence.
This case shows the importance of considering PVNS
for chronic pain of small joints, and it highlights the
viability for arthroscopic synovectomy as a treatment
option.
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INTRODUCTION
Pigmented villonodular synovitis (PVNS) is a rare
and proliferative condition of the synovium that is
associated with painful inflammation and recurrent
atraumatic hemarthrosis.1 PVNS predominately appears
in larger joints, thus the mainstays of surgical treatment
include both open and arthroscopic synovectomy.
Recurrence rates are as low as 0 to 9% for complete
synovectomy of localized or diffuse disease, but rates
can be as high as 56% with arthroscopic partial and
subtotal synovectomy.2 Although both arthroscopic and
open synovectomy are performed at larger joints such
as the hip and knee, case reports have only described
open debridement for PVNS at the wrist.3-6

CASE REPORT
A 43-year-old, right-hand dominant man presented with
right-wrist pain occurring after a mechanical fall onto
an extended wrist. The pain gradually worsened over 1
year and rendered him unable to complete his physical
fitness tests or perform tasks required for his job as
a military field technician. He described the pain as a

“dull ache,” and it did not improve with non-steroidal
anti-inflammatory drugs (NSAIDs). Nonoperative
treatment, including separate courses of physical
therapy and wrist immobilization, did not result in
lasting improvement of his symptoms. The patient
denied pertinent medical or family history. Physical
examination was significant for tenderness at the dorsal
aspect of the scaphotrapeziotrapezoidal (STT) joint,
between the second and third dorsal compartments.
His examination was otherwise unremarkable.
Dedicated x-rays of the wrist were without
abnormality. Magnetic resonance imaging (MRI)
localized a 17 mm x 10 mm x 8 mm mass to the dorsal
aspect of the scaphoid, adjacent to the STT joint. The
mass appeared with low to intermediate intensity on
T1- and T2-weighted images, with blooming artifact
on T2-gradient echo sequences and heterogeneous
enhancement after intravenous contrast administration,
consistent with PVNS (Figure 1).
The patient underwent arthroscopic excision of
a mass from the dorsal aspect of the STT joint. A
diagnostic arthroscopy of the radiocarpal joint was
first performed through the 3-4 viewing portal. A 6R
portal was established, and a limited debridement was
performed. No significant synovitis was appreciated.
Attention was then turned to the midcarpal joint.
A radial midcarpal portal was established, and a
diagnostic arthroscopy was performed. A dark yellow
mass was identified about the dorsal aspect of the STT
joint. An ulnar midcarpal portal was then established,
and the arthroscope was positioned through the portal
to view the mass. The shaver was advanced through
the radial midcarpal portal, and limited debridement
of connecting synovial tissue was performed to allow
for a marginal resection of the entire mass. The shaver
was removed, and the dorsal radial midcarpal portal
was extended proximally and distally to allow removal
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Figure 1. Coronal T2W fat sat, coronal proton-density no fat sat, and coronal T2* gradientecho images of the wrist showing a mass-like lesion centered in the scaphotrapeziotrapezoidal
joint, with intermediate to low signal intensity on all sequences (arrows). The adjacent osseous
structures are grossly unremarkable.
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Figure 2. Arthroscopic images showing A,B)
a rubbery, tan-yellow mass identified in the
scaphotrapeziotrapezoidal joint. Arthroscope in the
ulnar midcarpal portal, 2 mm probe in the radial
midcarpal portal. C) The lesion was removed intact.
of the entire mass with use of a grasper. After removal
of the mass en bloc, the shaver was re-inserted and
an arthroscopic synovectomy and debridement were
performed (Figure 2).
The mass measured 25 mm x 13 mm x 10 mm at the
time of excision, with pale yellow, brown, and mottled
cut surfaces. The mass showed active, hemosiderinladen zones as well as areas of histologic latency
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hallmarked by foamy, cholesterol-filled histiocytes.
A diagnosis of localized PVNS was made (Figure 3).
At 2 and 12 week follow-up, the patient reported
considerable improvements in his preoperative pain
level. The patient was advised to return at 1 year
postoperatively, but he was lost to follow-up. Just over
2 years postoperatively, the patient presented to our
orthopaedic sports clinic for chronic right-hip pain
and consented to a follow-up wrist examination. His
preoperative tenderness at the STT joint had resolved,
and his radial and ulnar deviation were within 5° of the
contralateral side. He was without subjective complaints
at that time, and he had returned to full duty with the
military.

DISCUSSION
PVNS is a benign though aggressive neoplastic disease
that is associated with the abnormal proliferative
growth of villi and nodules within the joint synovium.1
It is classified as either diffuse or localized, with a
respective prevalence of 11.5 and 44.5 per 100,000
persons, respectively.7
Diffuse PVNS exists as a global joint synovitis with
a large effusion and pressure-based erosions on both
the proximal and distal aspect of the joint.8 Commonly
termed “giant cell tumor of tendon sheath (GCTTS),”
localized PVNS exists as a solitary and pedunculated
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Figure 3. Findings of histopathology showing
A) localized-type tenosynovial tumor (2x). Wellcircumscribed and encapsulated polymorphous
proliferation of mononuclear cells admixed with
osteoclast-like giant cells and hemosiderin pigment
deposition. B) Localized-type tenosynovial tumor (40x).
The mononuclear cells are bland and include a mix
of spindled cells with uniform oval nuclei, and larger,
histiocytoid cells with more abundant eosinophilic
cytoplasm and reniform, vesicular nuclei. Also
present are multinucleated giant cells and associated
hemosiderin pigment.
mass, occurring either intra-articularly or extraarticularly intimate with a tendon sheath.8,9 Although
the most commonly affected joint is the knee, joint
involvement at various sites has been described.10
The exact cause of PVNS is unknown. Proposed
mechanisms include de novo development from
joint inflammation, via unregulated cell growth and
proliferation or by prior trauma.10-12 For this reason,
patient history alone may not implicate PVNS as a cause
of joint pain. Classic symptoms are less severe at smaller
joints and nondescript, including joint swelling, pain,
and loss of range of motion.10,12 Diagnosis thus depends
on radiology and histopathology. X-rays may show

soft tissue swelling and bony erosion; however, erosive
changes are often a later finding and typically found in
diffuse disease. For this reason, MRI can be particularly
helpful, as it will show low to intermediate uptake on
both T1- and T2-imaging, and gradient echo sequences
will show a pathognomonic blooming susceptibility
artifact of low signal intensity owing to the presence of
hemosiderin.13 Histologic specimen are grossly nodular
in appearance with characteristic microscopic features,
including hypertrophic villi, multinucleated giant cells,
and hemosiderin-laden foamy macrophages.9,13
The treatment of PVNS includes open versus
arthroscopic synovectomy for both diffuse and
localized disease. Radiation therapy may be used in
place of surgery or as an adjunctive therapy in PVNS
and GCTTS.14 Complete excision is advised to decrease
the chance of postoperative recurrence. This entails a
total synovectomy for diffuse disease, and the removal
of the entire lesion for localized disease.9,15 This is
particularly important, because even after reported total
synovectomies, recurrence rates between 9 to 44% have
been reported.14
This case highlights the diagnosis and treatment of
intra-articular localized PVNS of the STT joint. Despite
its location in an atypical joint, classic symptoms of pain
and range of motion loss were reported by our patient.
Despite normal x-rays, MRI showed the blooming
artifact associated with the presence of hemosiderin,
thus increasing the likelihood that the patient’s pain
was secondary to PVNS. This was confirmed on
histopathology when the specimen showed all the key
features of PVNS.
The current case also shows that arthroscopic
excision and synovectomy for PVNS at a small joint
(eg, STT joint) remains a viable treatment option.
Our patient lacked symptomatic recurrence 2 years
postoperatively. Arthroscopy allows for access and
complete visualization of smaller joints, including
magnification that may improve upon the resolution of
loupe magnification used with open synovectomy. In
this way, local recurrences may be diminished.
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